Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Functional and stereotactic neurosurgery

Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial.

Willemiek Zweiphenning; Maryse A van 't Klooster; Nicole E C van Klink; Frans S S Leijten; Cyrille H Ferrier; Tineke Gebbink; Geertjan Huiskamp; Martine J E van Zandvoort; Monique M J van Schooneveld; M Bourez; Sophie Goemans; Sven Straumann; Peter C van Rijen; Peter H Gosselaar; Pieter van Eijsden; Willem M Otte; Eric van Diessen; Kees P J Braun; Maeike Zijlmans; HFO study group

Originally published in The Lancet. Neurology · 2022-11-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background Intraoperative electrocorticography is used to tailor epilepsy surgery by analysing interictal spikes or spike patterns that can delineate epileptogenic tissue. High-frequency oscillations (HFOs) on intraoperative electrocorticography have been proposed as a new biomarker of epileptogenic tissue, with higher specificity than spikes. We prospectively tested the non-inferiority of HFO-guided tailoring of epilepsy surgery to spike-guided tailoring on seizure freedom at 1 year. Methods The HFO trial was a randomised, single-blind, adaptive non-inferiority trial at an epilepsy surgery centre (UMC Utrecht) in the Netherlands. We recruited children and adults (no age limits) who had been referred for intraoperative electrocorticography-tailored epilepsy surgery. Participants were randomly allocated (1:1) to either HFO-guided or spike-guided tailoring, using an online randomisation scheme with permuted blocks generated by an independent data manager, stratified by epilepsy type. Treatment allocation was masked to participants and clinicians who documented seizure outcome, but not to the study team or neurosurgeon.

Results

No participants were lost to follow-up (follow-up was 1 year for all patients). The primary endpoint analysis done at 1 year after surgery showed that 26 (67%) of 39 individuals in the HFO-guided group and 35 (90%) of 39 individuals in the spike-guided group were seizure-free (risk difference –23·5%, 90% CI –39·1 to –7·9; figure 2A).

Discussion

The findings of the HFO trial showed that, with respect to seizure outcome at 1 year, HFOs were not non-inferior to spikes on intraoperative electrocorticography for tailoring of epilepsy surgery, both overall and by epilepsy type (ie, temporal lobe epilepsy and extratemporal lobe epilepsy). Non-inferiority was not shown because the lower bound of the 90% CI for the risk difference was lower than –10%.

Editorial reading guide

  • How were patients or cases selected, and what did the authors use as a comparator?
  • Which outcomes, complications and follow-up intervals determine how far the findings apply?